Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Environmental Pollutants | 5 | 2018 | 320 | 1.35 | Why? |
| Gene-Environment Interaction | 5 | 2018 | 127 | 1.29 | Why? |
| Models, Genetic | 3 | 2017 | 434 | 1.29 | Why? |
| Community Health Workers | 2 | 2018 | 468 | 1.00 | Why? |
| Linear Models | 6 | 2018 | 1914 | 0.97 | Why? |
| Prostatic Neoplasms, Castration-Resistant | 3 | 2018 | 109 | 0.93 | Why? |
| Phthalic Acids | 2 | 2018 | 40 | 0.90 | Why? |
| Multifactorial Inheritance | 1 | 2018 | 78 | 0.70 | Why? |
| Biometry | 1 | 2017 | 69 | 0.67 | Why? |
| False Negative Reactions | 2 | 2021 | 1785 | 0.66 | Why? |
| Metals | 1 | 2017 | 182 | 0.59 | Why? |
| Models, Statistical | 6 | 2021 | 5312 | 0.58 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.56 | Why? |
| Developmental Disabilities | 1 | 2018 | 257 | 0.56 | Why? |
| Phenols | 4 | 2018 | 226 | 0.55 | Why? |
| India | 9 | 2021 | 11875 | 0.50 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.48 | Why? |
| Atherosclerosis | 2 | 2017 | 768 | 0.48 | Why? |
| Geography | 1 | 2018 | 1801 | 0.45 | Why? |
| Genome-Wide Association Study | 5 | 2018 | 1648 | 0.44 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2014 | 801 | 0.43 | Why? |
| Pregnancy Complications | 3 | 2018 | 1388 | 0.42 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.41 | Why? |
| Noise, Occupational | 2 | 2018 | 15 | 0.38 | Why? |
| Hearing Loss, Noise-Induced | 2 | 2018 | 15 | 0.38 | Why? |
| Rural Population | 2 | 2018 | 2408 | 0.38 | Why? |
| Bayes Theorem | 7 | 2021 | 3237 | 0.37 | Why? |
| Michigan | 3 | 2021 | 988 | 0.36 | Why? |
| Environmental Monitoring | 5 | 2019 | 3143 | 0.36 | Why? |
| Endocrine Disruptors | 2 | 2018 | 50 | 0.34 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.34 | Why? |
| Thyroid Hormones | 3 | 2018 | 213 | 0.33 | Why? |
| Smartphone | 1 | 2018 | 1840 | 0.33 | Why? |
| Genomics | 2 | 2018 | 3118 | 0.32 | Why? |
| Fetal Development | 2 | 2018 | 173 | 0.32 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.31 | Why? |
| African Americans | 2 | 2021 | 3363 | 0.31 | Why? |
| Maternal Exposure | 2 | 2017 | 173 | 0.30 | Why? |
| Disease | 2 | 2017 | 126 | 0.30 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.29 | Why? |
| Population Density | 2 | 2021 | 694 | 0.29 | Why? |
| Occupational Exposure | 6 | 2019 | 4742 | 0.29 | Why? |
| Referral and Consultation | 2 | 2018 | 4816 | 0.29 | Why? |
| Benzhydryl Compounds | 2 | 2017 | 240 | 0.27 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.27 | Why? |
| Boston | 4 | 2018 | 929 | 0.24 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.24 | Why? |
| Machine Learning | 2 | 2017 | 4395 | 0.23 | Why? |
| Pregnancy | 10 | 2018 | 23879 | 0.23 | Why? |
| Lead | 2 | 2018 | 94 | 0.21 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.21 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2018 | 3607 | 0.20 | Why? |
| Electronic Waste | 1 | 2019 | 22 | 0.20 | Why? |
| Practice Patterns, Physicians' | 2 | 2018 | 4927 | 0.20 | Why? |
| Risk Assessment | 4 | 2018 | 25439 | 0.20 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.19 | Why? |
| Kidney Diseases | 2 | 2020 | 1434 | 0.19 | Why? |
| Patella | 1 | 2018 | 23 | 0.19 | Why? |
| Acculturation | 1 | 2018 | 25 | 0.19 | Why? |
| Quantitative Trait, Heritable | 1 | 2018 | 26 | 0.19 | Why? |
| Carbanilides | 1 | 2018 | 4 | 0.19 | Why? |
| Air Pollutants, Occupational | 1 | 2019 | 108 | 0.19 | Why? |
| Environmental Exposure | 3 | 2018 | 1558 | 0.18 | Why? |
| Benzophenones | 1 | 2018 | 18 | 0.18 | Why? |
| Feasibility Studies | 2 | 2018 | 3467 | 0.18 | Why? |
| Phenol | 1 | 2017 | 24 | 0.18 | Why? |
| Mining | 1 | 2018 | 32 | 0.18 | Why? |
| Parabens | 2 | 2018 | 6 | 0.18 | Why? |
| Tibia | 1 | 2018 | 72 | 0.18 | Why? |
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2017 | 25 | 0.18 | Why? |
| Glaucoma, Open-Angle | 1 | 2018 | 55 | 0.17 | Why? |
| Neoplasm Metastasis | 2 | 2018 | 682 | 0.17 | Why? |
| Androstenes | 1 | 2017 | 65 | 0.17 | Why? |
| Meningitis, Pneumococcal | 1 | 2017 | 35 | 0.17 | Why? |
| Medicare Part D | 1 | 2017 | 28 | 0.17 | Why? |
| Bias | 3 | 2018 | 1109 | 0.17 | Why? |
| Humans | 49 | 2021 | 930598 | 0.17 | Why? |
| Calibration | 1 | 2018 | 307 | 0.17 | Why? |
| Longitudinal Studies | 5 | 2019 | 9893 | 0.17 | Why? |
| Computer Simulation | 4 | 2021 | 4982 | 0.17 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2020 | 6166 | 0.17 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.16 | Why? |
| Phenylthiohydantoin | 1 | 2017 | 87 | 0.16 | Why? |
| Thyroid Diseases | 2 | 2018 | 285 | 0.16 | Why? |
| Premature Birth | 3 | 2018 | 2151 | 0.16 | Why? |
| Metals, Heavy | 1 | 2018 | 147 | 0.16 | Why? |
| Incretins | 1 | 2016 | 61 | 0.15 | Why? |
| Regression Analysis | 3 | 2018 | 2484 | 0.15 | Why? |
| Epidemiologic Research Design | 1 | 2018 | 166 | 0.15 | Why? |
| Case-Control Studies | 7 | 2018 | 17671 | 0.15 | Why? |
| Thyrotropin | 1 | 2017 | 262 | 0.15 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.14 | Why? |
| Inhalation Exposure | 1 | 2019 | 405 | 0.14 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.14 | Why? |
| Biomarkers | 5 | 2018 | 23361 | 0.14 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.14 | Why? |
| Asian Americans | 1 | 2018 | 387 | 0.14 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.14 | Why? |
| Diagnostic Errors | 1 | 2020 | 865 | 0.13 | Why? |
| Pneumonia, Pneumococcal | 1 | 2017 | 251 | 0.13 | Why? |
| Measles Vaccine | 1 | 2017 | 301 | 0.13 | Why? |
| Odds Ratio | 3 | 2020 | 5861 | 0.13 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.13 | Why? |
| Female | 24 | 2021 | 380317 | 0.13 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.13 | Why? |
| Cooperative Behavior | 1 | 2021 | 1216 | 0.12 | Why? |
| Neoplasms | 2 | 2020 | 17251 | 0.12 | Why? |
| Thyroid Gland | 1 | 2018 | 516 | 0.12 | Why? |
| Feeding and Eating Disorders | 1 | 2019 | 525 | 0.12 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.12 | Why? |
| Insurance Coverage | 1 | 2017 | 348 | 0.12 | Why? |
| Occupational Diseases | 2 | 2018 | 2787 | 0.12 | Why? |
| Male | 22 | 2021 | 367725 | 0.12 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Wearable Electronic Devices | 1 | 2019 | 694 | 0.12 | Why? |
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 398 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| Child Abuse | 1 | 2019 | 504 | 0.12 | Why? |
| Socioeconomic Factors | 5 | 2021 | 8495 | 0.12 | Why? |
| Adult | 17 | 2021 | 244371 | 0.11 | Why? |
| Sample Size | 1 | 2014 | 518 | 0.11 | Why? |
| Rural Health Services | 1 | 2018 | 496 | 0.11 | Why? |
| Thyroxine | 3 | 2018 | 250 | 0.11 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.11 | Why? |
| Pneumococcal Vaccines | 1 | 2017 | 571 | 0.11 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.11 | Why? |
| Logistic Models | 4 | 2019 | 9089 | 0.11 | Why? |
| Measles | 1 | 2017 | 608 | 0.10 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.10 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.10 | Why? |
| Emigrants and Immigrants | 1 | 2018 | 888 | 0.10 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.10 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.10 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.09 | Why? |
| Software | 2 | 2017 | 2501 | 0.09 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.09 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.09 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.09 | Why? |
| Health Resources | 1 | 2021 | 2592 | 0.09 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.09 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Infant | 3 | 2018 | 30274 | 0.08 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.08 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.08 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.08 | Why? |
| Triiodothyronine | 2 | 2018 | 201 | 0.08 | Why? |
| Birth Weight | 2 | 2018 | 250 | 0.08 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.08 | Why? |
| Pregnant Women | 1 | 2018 | 2535 | 0.07 | Why? |
| Nutrition Surveys | 2 | 2018 | 287 | 0.07 | Why? |
| Child | 5 | 2021 | 70012 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.07 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.07 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.07 | Why? |
| United States | 7 | 2019 | 46150 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| Vulnerable Populations | 1 | 2018 | 3099 | 0.06 | Why? |
| Hypoglycemic Agents | 1 | 2016 | 2165 | 0.06 | Why? |
| Aged | 9 | 2021 | 215776 | 0.06 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.06 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.06 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.06 | Why? |
| Occupations | 2 | 2018 | 733 | 0.06 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Genetic Predisposition to Disease | 3 | 2018 | 4027 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| United States Occupational Safety and Health Administration | 1 | 2018 | 36 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Triclosan | 1 | 2018 | 17 | 0.05 | Why? |
| Normal Distribution | 1 | 2017 | 64 | 0.05 | Why? |
| Sulfones | 1 | 2018 | 66 | 0.04 | Why? |
| Hormones | 1 | 2018 | 66 | 0.04 | Why? |
| Hemochromatosis Protein | 1 | 2017 | 21 | 0.04 | Why? |
| Nasal Lavage | 1 | 2018 | 91 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Thyroid Function Tests | 1 | 2018 | 200 | 0.04 | Why? |
| Construction Industry | 1 | 2018 | 51 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.04 | Why? |
| Ghana | 1 | 2019 | 763 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| Biostatistics | 1 | 2017 | 116 | 0.04 | Why? |
| Sampling Studies | 1 | 2017 | 386 | 0.04 | Why? |
| Genetic Loci | 1 | 2017 | 439 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Self Concept | 1 | 2019 | 490 | 0.04 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.03 | Why? |
| Benzamides | 1 | 2017 | 421 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Depression | 1 | 2018 | 14116 | 0.03 | Why? |
| Ultrasonography, Prenatal | 1 | 2018 | 471 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Epidemiologic Methods | 1 | 2017 | 392 | 0.03 | Why? |
| Stress, Psychological | 1 | 2017 | 10231 | 0.03 | Why? |
| Massachusetts | 1 | 2018 | 1279 | 0.03 | Why? |
| Models, Psychological | 1 | 2017 | 383 | 0.03 | Why? |
| Video Recording | 1 | 2019 | 786 | 0.03 | Why? |
| Puerto Rico | 1 | 2013 | 177 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Databases, Factual | 2 | 2017 | 6248 | 0.03 | Why? |
| Nitriles | 1 | 2017 | 1053 | 0.03 | Why? |
| Infant, Newborn | 3 | 2018 | 23105 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2016 | 436 | 0.03 | Why? |
| Confidence Intervals | 1 | 2013 | 744 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2018 | 1142 | 0.03 | Why? |
| Lung | 1 | 2018 | 31049 | 0.02 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Particulate Matter | 1 | 2019 | 3249 | 0.02 | Why? |
| Uncertainty | 1 | 2018 | 1888 | 0.02 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.02 | Why? |
| Demography | 1 | 2013 | 1660 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Urology | 1 | 2017 | 1685 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Social Support | 1 | 2018 | 3183 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2016 | 7268 | 0.01 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.01 | Why? |
| Blood Glucose | 1 | 2016 | 3642 | 0.01 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Medical Oncology | 1 | 2017 | 3826 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2016 | 7330 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| China | 1 | 2017 | 50654 | 0.01 | Why? |